Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran

International Journal of Cancer

Volumn 131, Issue 2, 2012, Pages

  Khodakarami, Nahid ^a   Clifford, Gary M ^b   Yavari, Parvin ^a,c   Farzaneh, Farah ^a   Salehpour, Saghar ^a   Broutet, Natalie ^d   Bathija, Heli ^d   Heideman, Daniëlle A M ^e   Van Kemenade, Folkert J ^e   Meijer, Chris J L M ^e   Hosseini, Seyed Jalil ^a   Franceschi, Silvia ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Iranian Epidemiological Association   (Iran)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cervical cancer; human papillomavirus; Iran; prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DIVORCE; FAMILY LIFE; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUSBAND ABSENCE; IRAN; PAPILLOMAVIRUS INFECTION; POLYGAMY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IRAN; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84861623909     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26488     Document Type: Article

References (25)

1. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N,. Sexual behaviour in context: a global perspective. Lancet 2006; 368: 1706-28.
2. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8.
3. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S,. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 2009; 101: 202-8.
4. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ,. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 221-7.
5. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ,. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87.
6. De Vuyst H, Clifford G, Li N, Franceschi S,. HPV infection in Europe. Eur J Cancer 2009; 45: 2632-9.
7. Moore RA, Ogilvie G, Fornika D, Moravan V, Brisson M, Mirabbasi-Beik M, Kollar A, Burgess T, Hsu R, Towers L, Lo J, Matisic J, et al. Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women - implications for vaccination. Cancer Causes Control 2009; 20: 1387-96.
8. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677-84.
9. Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R,. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J 2002; 8: 805-11.
10. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A,. The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev 2002; 3: 69-72.
11. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, Yarandi F, Mousavi-Jarrahi A, Mohagheghi MA, Moradi A,. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 2006; 7: 529-32.
12. Esmaeili M, Bonyadi M, Dastranj A, Alizadeh M, Melli MS, Shobeiri MJ,. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest 2008; 66: 68-72.
13. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM,. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
14. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S,. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006; 95: 1593-7.
15. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJF, Huang RD, Sun LX, Meijer CJLM, Qiao YL, Franceschi S,. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006; 95: 96-101.
16. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S,. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007; 121: 1306-11.
17. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjanczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJ, Meijer CJ, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 2008; 44: 557-64.
18. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008; 17: 1731-8.
19. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders PJ, van Kemenade FJ, Meijer CJ, et al. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer 2010; 102: 1657-60.
20. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahé C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJLM, Weiderpass E,. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 601-6.
21. IARC. IARC handbooks of cancer prevention, vol. 10: Cervix cancer screening. Lyon: IARC Press, 2005.
22. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M,. Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med 2009; 12: 15-23.
23. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 2003; 107: 113-8.
24. Babaei M, Mousavi S, Malek M, Tosi G, Masoumeh Z, Danaei N, Gafar G,. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev 2005; 6: 159-64.
25. Somi MH, Farhang S, Mirinezhad SK, Naghashi S, Seif-Farshad M, Golzari M,. Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev 2008; 9: 327-30.